Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
scientific article published on 06 January 2021
Author/s
author: Amar Gajjar, Giles Robinson, Murali Chintagumpala, Eric Bouffet, Tim Hassall, Sridharan Gururangan, Michael Sullivan, Jordan Hansford, Stewart J Kellie, Clinton F Stewart, Alberto Broniscer, Ivo Buchhalter, Ruth G. Tatevossian, Brent A Orr, Paul Klimo, Frederick A Boop, Stefan M. Pfister, Richard Gilbertson, Arzu Onar-Thomas, Paul A Northcott, Thomas E Merchant, Ute Bartels, Geoffrey McCowage, Richard Cohn, Matthew J Krasin, Ashok Srinivasan
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.